# Moma Therapeutics 401(k) Plan
Source: https://planprovider.pro/companies/moma-therapeutics-401k-plan

> Moma Therapeutics's 401(k) plan: 59 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Moma Therapeutics

- **Sponsor EIN:** 834357140

- **Sponsor Address:** 20 ACORN PARK DRIVE, CAMBRIDGE, MA, 02140

- **Plan Type:** 401(k)

- **Total Participants:** 59

- **Total Assets:** $7.3M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** No

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|59|$7.3M|$520,886|$1.1M|

| 2023|63|$4.2M|$435,218|$904,196|

| 2022|58|$2.3M|$405,755|$814,558|

## Similar Plans

- [Lifemine Therapeutics, INC.](https://planprovider.pro/companies/lifemine-therapeutics-inc-401k-plan) — 58 participants

- [Invaio Sciences, INC.](https://planprovider.pro/companies/invaio-sciences-inc-401k-plan) — 60 participants

- [Sigilon Therapeutics, INC.](https://planprovider.pro/companies/sigilon-therapeutics-inc-401k-plan) — 62 participants

- [Xilio Development, INC.](https://planprovider.pro/companies/xilio-development-inc-401k-plan) — 62 participants

- [Aktis Oncology, INC.](https://planprovider.pro/companies/aktis-oncology-inc-401k-plan) — 62 participants

- [Repertoire Immune Medicines, INC](https://planprovider.pro/companies/repertoire-immune-medicines-inc-401k-plan) — 56 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/moma-therapeutics-401k-plan)

© 2026 PlanProvider.Pro